Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has acquired, through its subsidiary Meridian Life Science, Inc., substantially all of the assets of EUPROTEIN Inc. The transaction closed on April 30, 2022
Merger Arbitrage Mondays – WindAcre Doubles Its Stake In Nielsen Holdings (NLSN) And Other Deals
Merger activity decreased last week with three new deals announced and six deals completed.
Tivity Health (NASDAQ: TVTY)